Oxford BioMedica (GB:OXB) has released an update.
Oxford Biomedica, a leader in cell and gene therapy, has disclosed that their total number of voting rights stands at 100,013,988 following a recent share capital assessment. Shareholders can use this figure as a reference for mandatory notifications of interest changes as per FCA guidelines. The company, with over 25 years in the field, partners with top pharmaceutical firms and has facilities in the UK, France, and the US.
For further insights into GB:OXB stock, check out TipRanks’ Stock Analysis page.
